Dyne Therapeutics, Inc. - Common Stock (DYN)

Historical Holders from Q3 2020 to Q1 2025

Symbol
DYN on Nasdaq
CUSIP
26818M108
Type / Class
Equity / Common Stock
Shares outstanding
101M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
112M
Holdings value
$2.63B
% of all portfolios
0.008%
Grand Portfolio weight change
0%
Number of holders
198
Number of buys
96
Number of sells
-94
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dyne Therapeutics, Inc. - Common Stock (DYN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 7.9% $83.6M 8M FMR LLC Dec 31, 2024
JANUS HENDERSON GROUP PLC 7.3% $77.2M 7.38M JANUS HENDERSON GROUP PLC Dec 31, 2024
BlackRock, Inc. 5.8% $68.8M 6.58M BlackRock, Inc. Mar 31, 2025
RTW INVESTMENTS, LP 5.1% $54.6M 5.22M RTW Investments, LP Dec 31, 2024
Point72 Asset Management, L.P. 5.1% $54.4M 5.2M Point72 Asset Management, L.P. Jan 31, 2025

Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 594K $6.22M -$5.24M $10.46 10
2024 Q4 112M $2.63B -$30.1M $23.56 198
2024 Q3 112M $4.02B -$15.7M $35.92 201
2024 Q2 111M $3.92B +$557M $35.29 192
2024 Q1 95.3M $2.71B +$816M $28.39 167
2023 Q4 69.9M $930M +$32.1M $13.30 123
2023 Q3 59.9M $537M +$3.88M $8.96 114
2023 Q2 59M $664M +$48.6M $11.25 116
2023 Q1 54.6M $628M +$56.4M $11.52 124
2022 Q4 49.7M $576M +$50.4M $11.59 110
2022 Q3 42.7M $542M -$9.31M $12.70 95
2022 Q2 46.4M $319M -$7.88M $6.87 84
2022 Q1 46.9M $452M -$3.42M $9.64 87
2021 Q4 47.8M $568M +$18.8M $11.89 89
2021 Q3 32.2M $523M -$18M $16.24 79
2021 Q2 32.9M $692M +$24.4M $21.04 73
2021 Q1 31.4M $487M +$66M $15.53 72
2020 Q4 25.3M $532M +$16.5M $21.00 64
2020 Q3 24.2M $488M +$488M $20.19 48